Zobrazeno 1 - 10
of 90
pro vyhledávání: '"Leif Bostad"'
Autor:
Philipp Strauss, Mariell Rivedal, Andreas Scherer, Øystein Eikrem, Sigrid Nakken, Christian Beisland, Leif Bostad, Arnar Flatberg, Eleni Skandalou, Vidar Beisvåg, Jessica Furriol, Hans-Peter Marti
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-15 (2022)
Abstract Clear cell renal cell carcinoma (ccRCC) is the most common renal cancer. Identification of ccRCC likely to progress, despite an apparent low risk at the time of surgery, represents a key clinical issue. From a cohort of adult ccRCC patients
Externí odkaz:
https://doaj.org/article/4eeaf6c69c79445dafaf83fb89e0844a
Autor:
Yngvar Lunde Haaskjold, Rune Bjørneklett, Leif Bostad, Lars Sigurd Bostad, Njål Gjærde Lura, Thomas Knoop
Publikováno v:
BMC Nephrology, Vol 23, Iss 1, Pp 1-11 (2022)
Abstract Background The Oxford classification/MEST score is an established histopathologic scoring system for patients with IgA nephropathy (IgAN). The objective of this study was to derive a prognostic model for IgAN based on the MEST score and hist
Externí odkaz:
https://doaj.org/article/cf1022b754d14757a8709abdeb012efa
Autor:
Sigrid Nakken, Øystein Eikrem, Hans-Peter Marti, Christian Beisland, Leif Bostad, Andreas Scherer, Arnar Flatberg, Vidar Beisvag, Eleni Skandalou, Jessica Furriol, Philipp Strauss
Publikováno v:
Cancer Cell International, Vol 21, Iss 1, Pp 1-12 (2021)
Abstract Background Clear cell renal cell carcinoma (ccRCC) is the most common subtype of renal cancer and one of the most common cancers. While survival for localized ccRCC is good, the survival of metastatic disease is not, and thirty percent of pa
Externí odkaz:
https://doaj.org/article/833c96fba2c94c27b5517c4efa0a602b
Autor:
Martin Pilskog, Christian Beisland, Lars A. Akslen, Leif Bostad, Åse Haug, Daniel Heinrich, Karin M. Hjelle, Oddbjørn Straume
Publikováno v:
BMC Urology, Vol 17, Iss 1, Pp 1-11 (2017)
Abstract Background Sunitinib has become mainstay first line treatment for patients with metastatic renal clear cell carcinoma (mRCC). Still, useful predictive markers of response are lacking and urgently needed for clinical decision making. Methods
Externí odkaz:
https://doaj.org/article/ed1d653b020c467fbb75ed8c50cc3643
Autor:
Sanjeevan Sriskandarajah, Leif Bostad, Tor Åge Myklebust, Bjørn Møller, Steinar Skrede, Rune Bjørneklett
Publikováno v:
International Journal of Nephrology, Vol 2017 (2017)
Background. Immunosuppressive therapy for antineutrophil cytoplasmic antibody-associated vasculitis has been associated with increased malignancy risk. Objectives. To quantify the cancer risk associated with contemporary cyclophosphamide-sparing prot
Externí odkaz:
https://doaj.org/article/1bd7021d924e4bf1bccb9a1816614b73
Autor:
Yngvar Lunde Haaskjold, Njål Gjærde Lura, Rune Bjørneklett, Leif Bostad, Lars Sigurd Bostad, Thomas Knoop
Publikováno v:
gfac225
Nephrology, Dialysis and Transplantation
Nephrology, Dialysis and Transplantation
Background Recently, two immunoglobulin A (IgA) nephropathy-prediction tools were developed that combine clinical and histopathologic parameters. The International IgAN Prediction Tool predicts the risk for 50% declines in the estimated glomerular fi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8658f361b95ab99a76ece530f6d93f8d
https://hdl.handle.net/11250/3031070
https://hdl.handle.net/11250/3031070
Publikováno v:
Tidsskrift for Den norske legeforening.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::584a8bd62556d6259abf90e7273a06fd
https://doi.org/10.4045/tidsskr.21.0115
https://doi.org/10.4045/tidsskr.21.0115
Autor:
Gigja Gudbrandsdottir, Øystein Bruserud, Karin M. Hjelle, Leif Bostad, Helene Hersvik Aarstad, Hans Jørgen Aarstad, Tor Henrik Anderson Tvedt, Christian Beisland
Publikováno v:
Cancer Immunology, Immunotherapy
Cancer Immunology and Immunotherapy
19–30
Cancer Immunology and Immunotherapy
19–30
Purpose An improved understanding of RCC immunology should shed further light on RCC tumor biology. Our objective was to study to what extent serum levels of the IL-6 family of cytokines at diagnosis were relevant to survival. Methods A total of 118
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8465edde97f15b02c9450369a82e0c17
https://pubmed.ncbi.nlm.nih.gov/32621022
https://pubmed.ncbi.nlm.nih.gov/32621022
Autor:
Gigja Guðbrandsdottir, Christian Beisland, Helene Hersvik Aarstad, Øystein Bruserud, Karin M. Hjelle, Leif Bostad, Tor Henrik Anderson Tvedt
Publikováno v:
Cancers
12:1961
Cancers, Vol 12, Iss 1961, p 1961 (2020)
Volume 12
Issue 7
12:1961
Cancers, Vol 12, Iss 1961, p 1961 (2020)
Volume 12
Issue 7
High serum levels of the acute phase protein C-reactive protein (CRP) are associated with an adverse prognosis in renal cancer. The acute phase reaction is cytokine-driven and includes a wide range of inflammatory mediators. This overall profile of t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d3d57106d681f4f504c45fa1c165d8a
https://hdl.handle.net/11250/2728841
https://hdl.handle.net/11250/2728841
Publikováno v:
Pathology Research International, Vol 2018 (2018)
Pathology Research International
Pathology Research International
Background. Classification of patients with anti-neutrophil cytoplasmic antibody-associated glomerulonephritis (ANCA-GN) into histological classes is useful for predicting a patient’s risk of progression to end-stage renal disease (ESRD). However,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c131b2d3ee43572970d99fc10dc11bc
https://doi.org/10.1155/2018/5653612
https://doi.org/10.1155/2018/5653612